Johnson & JohnsonJNJNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+14.5%
5Y CAGR+10.8%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+14.5%/yr
vs +0.6%/yr prior
5Y CAGR
+10.8%/yr
Recent acceleration
Acceleration
+13.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $39.90B | +61.0% |
| 2024 | $24.78B | +6.3% |
| 2023 | $23.32B | -12.3% |
| 2022 | $26.61B | -0.5% |
| 2021 | $26.75B | +11.8% |
| 2020 | $23.93B | -2.9% |
| 2019 | $24.66B | -4.9% |
| 2018 | $25.93B | +6.9% |
| 2017 | $24.25B | -0.1% |
| 2016 | $24.28B | - |